Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Main Index

View All
A10AB06 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Diabetic Ketoacidosis Follow-Up of Type 1 Diabetes Hyperglycaemic Hyperosmolar Syndrome Hyperkalaemia Pharmacological Glucocorticoid Treatment Type 1 Diabetes: Treatment
A10AC01 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Follow-Up of Type 1 Diabetes Hyperglycaemic Hyperosmolar Syndrome Insulin Therapy in Type 2 Diabetes Pharmacological Glucocorticoid Treatment Type 1 Diabetes: Treatment
A10AC03 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Follow-Up of Type 1 Diabetes Hyperglycaemic Hyperosmolar Syndrome Pharmacological Glucocorticoid Treatment
A10AE02 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Type 1 Diabetes: Treatment
A10AE04 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Insulin Therapy in Type 2 Diabetes Type 1 Diabetes: Treatment
A10AE05 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Insulin Therapy in Type 2 Diabetes Type 1 Diabetes: Treatment
A10AE06 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Type 1 Diabetes: Treatment
A10AE54 A Child or Adolescent with Type 1 Diabetes in Primary Health Care Type 1 Diabetes: Treatment
A10BA02 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Diabetic Kidney Disease (Diabetic Nephropathy) Excessive Hair Growth (Hirsutism) Oral Antidiabetic Drugs and GLP-1 Analogues Polycystic Ovary Syndrome (PCOS)
A10BB01 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Hypoglycaemia in the Absence of Diabetes in Adults Oral Antidiabetic Drugs and GLP-1 Analogues
A10BB07 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Hypoglycaemia in the Absence of Diabetes in Adults Oral Antidiabetic Drugs and GLP-1 Analogues
A10BB12 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Diabetic Kidney Disease (Diabetic Nephropathy) Hypoglycaemia in the Absence of Diabetes in Adults Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD03 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD05 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD07 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD08 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD09 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD10 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD11 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD13 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD15 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD19 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD20 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD21 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD23 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BD24 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues
A10BG02
A10BG03 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Diabetic Kidney Disease (Diabetic Nephropathy) Oral Antidiabetic Drugs and GLP-1 Analogues
A10BH01 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Diabetic Kidney Disease (Diabetic Nephropathy) Oral Antidiabetic Drugs and GLP-1 Analogues
A10BH02 Comprehensive Treatment and Follow-Up of Type 2 Diabetes Diabetic Kidney Disease (Diabetic Nephropathy) Oral Antidiabetic Drugs and GLP-1 Analogues